openPR Logo
Press release

Presbyopia Treatment Market 2025 | Market Growth, Advanced IOLs, Drug Launches & Non-invasive Solutions

08-12-2025 02:28 PM CET | Health & Medicine

Press release from: DataM Intelligence 4Market Research LLP

Presbyopia Treatment Market

Presbyopia Treatment Market

"The Presbyopia Treatment Market reached US$8,142.75 Million in 2023, with a rise of US$8,690.02 Million in 2024, and is expected to reach US$17,606.02 Million by 2033, growing at a CAGR of 8.3% during the forecast period 2025-2033, as per DataM Intelligence research report" as per DataM intelligence research report.

Presbyopia Treatment Market: Recent Industry Developments
United States
✅ In April 2024, Lenz Therapeutics reported positive late-stage (Phase 3) results for LNZ100 (presbyopia eye-drop), showing robust near-vision improvement without loss of distance vision.LNZ100's pivotal data accelerated regulatory momentum for a new once-daily pharmacologic option for presbyopia.
✅ In July 2024, Lenz secured a $30M PIPE investment from Ridgeback Capital to support late-stage development and commercialization readiness. The financing strengthened Lenz's balance sheet ahead of NDA review and commercial planning.
✅ In October 2024, Orasis & industry players moved toward commercial rollout: Orasis closed $78M to support the U.S. launch of QLOSI and Lenz announced FDA NDA acceptance (PDUFA Aug 8, 2025). These milestones mark a shift from R&D to commercial execution in the presbyopia-drop category.

Japan
✅ In 2025, Japanese regulators will continue policy moves to reduce the 'drug-lag' and accelerate approvals, improving the pathway for innovative ophthalmic therapies.
Regulatory modernization in 2025 is making Japan a faster follow-on market for presbyopia drugs and devices.
✅ In 2025 (planned late-2025 rollouts), Major IOL manufacturers signalled broader global rollouts (e.g., Alcon's Clareon PanOptix Pro) with additional markets slated for late-2025.That global launch cadence suggests Japan could see new presbyopia-correcting IOL introductions in the coming months.
✅ In June 20 2023, BVI Medical launched the FINEVISION HP hydrophobic trifocal IOL in Japan, expanding presbyopia-correcting IOL options for Japanese cataract patients.This launch reflects growing surgeon and patient adoption of trifocal/EDOF solutions in Japan's mature IOL market.

Download your exclusive sample report today: (corporate email gets priority access): https://www.datamintelligence.com/download-sample/presbyopia-treatment-market?jd

Market growth opportunities (2025-2031):

The Presbyopia treatment market is set for substantial expansion through 2031, propelled by a rising aging population and escalating demand for effective vision-correction solutions. Innovations in contact lenses, therapeutic eye drops, and minimally invasive procedures are opening new frontiers in treatment delivery. Increasing public awareness and favorable regulatory developments further bolster market traction. Geographically, the Asia-Pacific region stands out for accelerated adoption, while North America remains a stable, mature market. Altogether, these dynamics create a favorable environment for emerging technologies and novel therapies to flourish.

Presbyopia Treatment Market: Technological Advancements

✦ Adaptive and pharmacologic therapies - Ongoing R&D efforts include advanced eye drop formulations (e.g., miotic agents) and miotic/pharmacologic combinations that aim to restore accommodation with greater precision and fewer side effects.
✦ Corneal inlays and diffractive implants - Developments like diffractive corneal inlays leverage optical diffraction to enhance near vision, offering minimally invasive and effective treatment options.
✦ Laser-based surgical solutions - Procedures such as Laser Blended Vision customize the optics of each eye to improve depth of focus, enabling clear near, intermediate, and distance vision without spectacles.
✦ Intraocular lens (IOL) innovations - Next-generation presbyopia-correcting IOLs, including multifocal and Symfony designs, are delivering broader vision ranges post-implantation, reducing reliance on glasses.
✦ Digital diagnostics and AI integration - Emerging lens technologies and diagnostic tools are incorporating AI and imaging advancements to personalize treatment and improve outcomes.

Presbyopia Treatment Market: Drivers

Aging populations globally are significantly increasing presbyopia prevalence, intensifying demand for vision-correction options. Concurrently, expanding access to and awareness of non-invasive treatments such as eye drops and advanced contact lenses-are reshaping patient preferences. Technological breakthroughs across pharmacologic, optical, and surgical domains are enabling more effective and convenient solutions. Regulatory approvals and clinical validation build confidence among users and clinicians alike. Additionally, rising disposable incomes in emerging markets are supporting the adoption of premium treatment modalities.

Get Customization in the report as per your requirements: https://www.datamintelligence.com/customize/presbyopia-treatment-market?jd

Segment Covered in the Presbyopia Treatment Market:

➥ By Type: Incipient Presbyopia, Functional Presbyopia, Absolute Presbyopia, Premature Presbyopia, Nocturnal Presbyopia
➥ By Treatment: Eyeglasses, Contact Lenses, Surgeries, Eye Drops, Others
➥ By End-User: Hospitals, Ophthalmic Clinics, Ambulatory Surgical Centers, Others

Strategic Players Driving the Presbyopia Treatment Market Forward:

Key players are Alcon Vision LLC, Novartis AG, Eyenovia, Johnson and Johnson Pvt Ltd, Ocuphire Pharma Inc, Allergan, Visus Therapeutics, Ziemer Ophthalmic Systems, Sun Pharmaceutical Industries Ltd, and F. Hoffmann-La Roche Ltd., among others.

Why Purchase the Report for the Presbyopia Treatment Market?

➠ Technology & Innovation: Tracks clinical trials and upcoming pharmaceutical advancements to stay ahead in product development.
➠ Market Positioning & Competitive Strategy: Analyzes product performance, market share, and competitor tactics for strategic decision-making.
➠ Real-World Evidence & Physician Insights: Incorporates patient data and physician behavior to align products with actual healthcare needs.
➠ Pricing & Market Access: Reviews reimbursement trends and access models to optimize product pricing and launch strategies.
➠ Regulatory & Industry Shifts: Covers policy changes, health system dynamics, and technology trends impacting market opportunities.
➠ Regional Growth & Expansion: Identifies high-growth markets and investment opportunities for geographic expansion.

Buy Now & Unlock 360° Market Intelligence: https://www.datamintelligence.com/buy-now-page?report=presbyopia-treatment-market

Regional Analysis for Presbyopia Treatment Market:

North America currently dominates the market, benefiting from sophisticated healthcare systems, high patient awareness, and strong adoption of advanced therapies. Meanwhile, the Asia-Pacific is emerging as the fastest-growing region, driven by its expanding geriatric population, increasing healthcare investment, and rising awareness of corrective ophthalmic options. Europe also maintains steady growth, supported by well-established infrastructure and continued innovation.

Request for 2 Days FREE Trial Access:
https://www.datamintelligence.com/reports-subscription?jd

✅ Technology Roadmap Analysis
✅ Sustainability Impact Analysis
✅ KOL / Stakeholder Insights
✅ Pipeline Analysis For Drug Discovery
✅ Positioning, Pricing & Market Access Snapshots
✅ Market Volatility & Emerging Risks Analysis
✅ Competitive Landscape

Have a look at our Subscription Dashboard:
https://www.youtube.com/watch?v=x5oEiqEqTWg

Contact Us -
Company Name: DataM Intelligence
Contact Person: Sai Kiran
Email: Sai.k@datamintelligence.com
Phone: +1 877 441 4866
Website: https://www.datamintelligence.com

About Us -
DataM Intelligence is a Market Research and Consulting firm that provides end-to-end business solutions to organizations from Research to Consulting. We, at DataM Intelligence, leverage our top trademark trends, insights and developments to emancipate swift and astute solutions to clients like you. We encompass a multitude of syndicate reports and customized reports with a robust methodology.
Our research database features countless statistics and in-depth analyses across a wide range of 6300+ reports in 40+ domains creating business solutions for more than 200+ companies across 50+ countries; catering to the key business research needs that influence the growth trajectory of our vast clientele.

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Presbyopia Treatment Market 2025 | Market Growth, Advanced IOLs, Drug Launches & Non-invasive Solutions here

News-ID: 4142228 • Views:

More Releases from DataM Intelligence 4Market Research LLP

Maternal Health Market 2025 | Market Growth, Digital Health Innovation & Key Initiatives Drive Global Expansion
Maternal Health Market 2025 | Market Growth, Digital Health Innovation & Key Ini …
The Maternal Health Market reached US$14.1 billion in 2022 and is expected to reach US$28.3 billion by 2030, growing with a CAGR of 8.5% during the forecast period 2023-2030, as per DataM Intelligence research report" as per the DataM intelligence research report. Maternal Health Market: Recent Industry Developments United States ✅ In Aug 2025, MAC Cosmetics launched a maternal health initiative through the Viva Glam Fund, providing a $200,000 grant to BirthFund and
Hermansky Pudlak Syndrome Market 2025 | Growth Driven by Novel Therapies, Global Expansion & Key Pipeline Advances
Hermansky Pudlak Syndrome Market 2025 | Growth Driven by Novel Therapies, Global …
Hermansky-Pudlak Syndrome Market is anticipated to grow at a promising CAGR during the forecast period 2024-2031, as per DataM Intelligence research report" as per the DataM intelligence research report. Hermansky-Pudlak Syndrome Market: Recent Industry Developments United States: ✅ In June 2025, A major review summarizing molecular pathogenesis and therapeutic directions for HPS was published, highlighting new research avenues.The review consolidates recent gene, cell and fibrosis-targeting insights that will guide translational and drug-repurposing
Additive Manufacturing in Aerospace, Automotive & Healthcare: 2025 Market Trends and Growth Outlook | Major Companies are Stratasys, 3D Systems, EOS GmbH
Additive Manufacturing in Aerospace, Automotive & Healthcare: 2025 Market Trends …
The Global Additive Manufacturing Market reached USD 14 billion in 2022 and is projected to witness lucrative growth by reaching up to USD 62 billion by 2031. The market is growing at a CAGR of 24.5% during the forecast period 2024-2031 Additive Manufacturing, commonly known as 3D printing, is a process of creating three-dimensional objects layer by layer using digital design data. It enables rapid prototyping, customization, complex geometries, and reduced
Next-Gen Data Center Infrastructure Management: Merging AI, IoT & Green Practices for Future-Ready Data Centers
Next-Gen Data Center Infrastructure Management: Merging AI, IoT & Green Practice …
Global Data Center Infrastructure Management Market size reached US$ 2,001.6 million in 2022 and is projected to witness lucrative growth by reaching up to US$ 4,154.1 million by 2031. The market is growing at a CAGR of 13.8% during the forecast period (2024-2031). DCIM solutions enable centralized control of data center operations monitoring power, cooling, networks, assets, and environmental conditions in real time. They automate workflows, improve resource utilization, ensure uptime,

All 5 Releases


More Releases for Presbyopia

Presbyopia Pipeline Assessment Report 2025 | DelveInsight
DelveInsight's, "Presbyopia Pipeline Insight, 2025" report provides comprehensive insights about 10+ companies and 10+ pipeline drugs in Presbyopia pipeline landscape. It covers the Presbyopia pipeline drug profiles, including clinical and nonclinical stage products. It also covers the Presbyopia pipeline therapeutics assessment by product type, stage, route of administration, and molecule type. It further highlights the inactive pipeline products in this space. Discover the latest drugs and treatment options in the Presbyopia
Rising Geriatric Population Fuels Growth Of Myopia And Presbyopia Treatment Mark …
The Myopia and Presbyopia Treatment Market Report by The Business Research Company delivers a detailed market assessment, covering size projections from 2025 to 2034. This report explores crucial market trends, major drivers and market segmentation by [key segment categories]. What Is the Myopia and Presbyopia Treatment Market Size and Projected Growth Rate? The market size for myopia and presbyopia treatment has witnessed substantial growth over several recent years. The market is projected
Presbyopia Treatment Market Trends And Industry Forecast 2024-2031
Presbyopia Treatment Market: Trends Shaping the Industry The presbyopia treatment market is experiencing significant growth, driven by a surge in the global aging population. As people live longer, the demand for effective solutions to age-related vision problems like presbyopia increases. This trend is fueling research and development efforts, leading to the introduction of innovative therapeutics like advanced contact lenses and eye drops. Market Segmentation: Addressing Diverse Needs The presbyopia treatment market is segmented
Presbyopia Treatment Market Growth Analysis 2023-2030
Global Presbyopia Treatment Market Gains Momentum Amidst Rising Aging Population and Innovations in Therapeutics: The global presbyopia treatment market has witnessed substantial growth in recent years, fueled by the increasing prevalence of presbyopia and the expanding aging population. Presbyopia, a common vision loss associated with aging, has prompted a surge in demand for effective treatments, leading to advancements in eyeglasses, contact lenses, surgeries, eye drops, and nutrient-based interventions. Refractive surgeries, including Conductive
Presbyopia Pipeline: Insights into Novel Pipeline Therapies, Key Pharma Companie …
DelveInsight's, "Presbyopia Pipeline Insight, 2022," report provides comprehensive insights about 12+ companies and 12+ pipeline drugs in Presbyopia pipeline landscape. It covers the pipeline drug profiles, including clinical and nonclinical stage products. It also covers the therapeutics assessment by product type, stage, route of administration, and molecule type. It further highlights the inactive pipeline products in this space. Key takeaways from the Presbyopia Pipeline Insight Report • Presbyopia Pipeline report offers a comprehensive
Presbyopia Market 2020-2027 Sets the Table for Continued Growth || Top Growing C …
A transparent research method has been accomplished with the right tools and techniques to make this Presbyopia Market research report world-class. Two of the most widely used techniques namely SWOT analysis and Porter's Five Forces Analysis have been used while generating this report. Competitive analysis conducted in this report puts light on the moves of the key players in the Healthcare industry such as new product launches, expansions, agreements, joint